ReviewCancer cell international2026
Unraveling the complexity of pyroptosis in esophageal cancer: from underlying mechanisms to targeted therapies.
Review in Cancer cell international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pyroptosis is a form of programmed cell death mediated by caspases, characterized by the activation of Gasdermin proteins, which leads to cell membrane rupture and the release of inflammatory mediators, thereby inducing local inflammation. In recent years, pyroptosis has emerged as an important player in tumorigenesis and progression, particularly in esophageal cancer (EC). EC is a highly malignant digestive system tumor, often diagnosed at advanced stages due to its subtle early symptoms, resulting in a poor prognosis. Studies have shown that pyroptosis not only regulates the immune response in EC but also influences tumor proliferation, invasion, and drug resistance. Activating pyroptosis may help overcome drug resistance in cancer cells, offering potential therapeutic targets for novel drug development and providing new directions for prognostic evaluation in EC. This review summarizes the mechanisms of pyroptosis and its role in EC, aiming to provide a theoretical basis for clinical treatment and drug development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.